MJH Life Sciences™ Adds Four Renowned Health Care Experts to its COVID-19 Coalition

MJH Life Sciences™, the privately owned health care media company, has expanded its COVID-19 Coalition to include four additional members with expertise in infectious disease, psychiatry, and global health and epidemiology.

CRANBURY, N.J.--(BUSINESS WIRE)-- MJH Life Sciences™, the privately owned health care media company, has expanded its COVID-19 Coalition to include four additional members with expertise in infectious disease, psychiatry, and global health and epidemiology.

Borne from a need for reliable, up-to-the-minute information for health care providers navigating the pandemic, the MJH Life Sciences™ COVID-19 Coalition brings together nationally recognized thought leaders to bridge informational gaps for those working on the frontlines.

Through a series of biweekly webinars, whitepapers and other resources, the Coalition addresses the topics generating the most interest and questions among providers, from vaccine development updates to the anticipated impact of influenza on the disease.

The newest members of the MJH Life Sciences™ COVID-19 Coalition advisory panel are:

  • Carlos del Rio, M.D., distinguished professor of medicine, Emory University School of Medicine; professor of global health and epidemiology, Rollins School of Emory University; executive associate dean, Emory University School of Medicine at Grady Health System; and codirector and principal investigator of the Emory Center for AIDS Research.
  • Amesh Adalja, M.D., FIDSA, senior scholar, Johns Hopkins University Center for Health Security.
  • Rachna Kalia, M.D., clinical assistant professor of psychiatry, KU School of Medicine-Wichita. KU Wichita Psychiatry.
  • Utibe R. Essien, M.D., MPH, assistant professor of medicine, University of Pittsburgh, School of Medicine; core investigator, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System.

“Registration numbers for our highly rated COVID-19 Coalition webinars continue to increase, which speaks not only to the topical interest but the need for this information,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™. “The addition of Drs. del Rio, Adalja, Kalia, and Essien round out our powerful team of experts who have joined us to help health care providers administer the best patient care possible amidst the COVID-19 pandemic.”

The MJH Life Sciences™ COVID-19 Coalition will host its next event, “Navigating the COVID-19 Treatment Landscape, a free, live, one-hour webinar on Tuesday, Oct. 13, at 6 p.m. EDT. To register, click here.

To learn more about the MJH Life Sciences™ COVID-19 Coalition, click here.

About MJH Life Sciences™

MJH Life Sciences is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH Life Sciences™ combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/.

Contacts

MJH Life Sciences™ Media Contact
Alexandra Ventura, 609-716-7777
aventura@mjhlifesciences.com

Source: MJH Life Sciences™

MORE ON THIS TOPIC